Patient Guide: A Study of Real Life Treatment for Multiple Myeloma (MM)

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 24 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT04985643
Status: ACTIVE_NOT_RECRUITING
Condition: Multiple Myeloma
Phase: Not Specified

Where You Can Participate

This study is available at 24 locations across the country.

Top locations include:
  • • Barnaul, Altay Region
  • • Kaluga, Central Federal District
  • • Smolensk, Central Federal District
  • • And 21 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study of Real Life Treatment for Multiple Myeloma (MM) - Join Clinical Trial NCTNCT04985643

How to Join This Clinical Trial - NCTNCT04985643

Learn how to participate in this Not Specified trial studying an investigational therapy for Multiple Myeloma. Current status: ACTIVE_NOT_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Multiple Myeloma. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Multiple Myeloma
Treatment Being Tested
Investigational treatment
Study Phase
Not Specified - Research study
Enrollment Status
ACTIVE_NOT_RECRUITING
Study Identifier
NCTNCT04985643 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 24 locations. Find a study site near you:

Clinical Research Site

Barnaul, Altay Region 656024 - Russian Federation

Status: Contact for availability

Clinical Research Site

Kaluga, Central Federal District 248007 - Russian Federation

Status: Contact for availability

Clinical Research Site

Smolensk, Central Federal District 214025 - Russian Federation

Status: Contact for availability

Clinical Research Site

Khabarovsk, Far Eastern Federal District 680009 - Russian Federation

Status: Contact for availability

Clinical Research Site

Kirov, Kirov Region 610027 - Russian Federation

Status: Contact for availability

Clinical Research Site

Lipetsk, Lipetsk Region 398007 - Russian Federation

Status: Contact for availability

Clinical Research Site

Moscow, Moscow Region 125167 - Russian Federation

Status: Contact for availability

Clinical Research Site

Moscow, Moscow Region 125284 - Russian Federation

Status: Contact for availability

Clinical Research Site

Moscow, Moscow Region 129110 - Russian Federation

Status: Contact for availability

Clinical Research Site

Kaliningrad, Northwestern Federal District 238022 - Russian Federation

Status: Contact for availability

And 14 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this Not Specified clinical trial for Multiple Myeloma:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships